When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
SNGX - Soligenix: Two Phase-3 Clinical Trials - Results By June 2020
Soligenix Inc.
Soligenix is a small biotech company that will announce results from two separate PH 3 clinical trials: FLASH study SGX301 in patients with cutaneous T cell lymphoma (CTCL) will be announced in 2 months, and top-line results of DOM-INNATE study of SGX942 for the treatment of oral mucositis in patients with concomitant chemoradiotherapy for Head and Neck cancer are expected 4 months after that.
Cutaneous T cell lymphoma (CTCL) is a rare type of lymphoma and there is no FDA approved therapy for the early stage of the disease. It is estimated that around 20